Matinas BioPharma Holdings, Inc. (MTNB)
NYSE American · Manufacturing · Pharmaceutical preparations
$2.53+$0.1300 (+5.42%) on the dayAs of the close; data may be delayed.
MTNB price, last 12 months
Key stats
- Previous close
- $2.40
- Open
- $2.47
- Day range
- $2.34 – $2.65
- 52-week range
- $2.26 – $29.85
- Volume
- 117.3K
- Avg volume (20 days)
- 54.4K
- Market cap
- $2.6M
Performance
1W−3.0%
1M−15.7%
3M−74.6%
6M−69.9%
YTD−71.2%
1Y−91.0%
vs S&P 500, 1Y−107.4 pts
Technicals and fundamentals
About Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NYSE American
- Market cap
- $2.6M